Incidence and survival after acute myocardial infarction in indigenous and non-indigenous people in the Northern Territory, 1992-2004 by You, Jiqiong et al.
RESEARCHIncidence and survival after acute myocardial infarction 
in Indigenous and non-Indigenous people in the 
Northern Territory, 1992–2004
Jiqiong You, John R Condon, Yuejen Zhao and Steven GuthridgeThe Medical Journal of Australia ISSN:
0025-729X 16 March 2009 190 6 298-
302
©The Medical Journal of Australia 2009
www.mja.com.au
Research
every year for men and 3.0% for women.1,2
This fall has been attributed, in part, to a
decrease in IHD incidence, largely a result of
reduced tobacco use.3,4 Better s rvival rates
with improved tre tment have also been
cited as a factor,3 but there are no national








Objective:  To estimate the incidence and survival rates of acute myocardial infarction 
(AMI) for Northern Territory Indigenous and non-Indigenous populations.
Design and participants:  Retrospective cohort study for all new AMI cases recorded in 
ital inpatient data or registered as an ischaemic heart disease (IHD) death between 
 and 2004.
 outcome measures:  Population-based incidence and survival rates by age, sex, 
enous status, remoteness of residence and year of diagnosis.
lts:  Over the 13-year study period, the incidence of AMI increased 60% in the 
digenous population (incidence rate ratio [IRR], 1.04; 95% CI, 1.02–1.06), but 
ased 20% in the non-Indigenous population (IRR, 0.98; 95% CI, 0.97–1.00). Over the 
same period, there was an improvement in all-cases survival (ie, survival with and without 
hospital admission) for the NT Indigenous population due to a reduction in deaths both 
pre-hospital and after hospital admission (death rates reduced by 56% and 50%, 
respectively). The non-Indigenous all-cases death rate was reduced by 29% as a 
consequence of improved survival after hospital admission; there was no significant 
change in pre-hospital survival in this population. Important factors that affected 
outcome in all people after AMI were sex (better survival for women), age (survival 
declined with increasing age), remoteness (worse outcomes for non-Indigenous 
residents of remote areas), year of diagnosis and Indigenous status (hazard ratio, 1.44; 
95% CI, 1.21–1.70).
Conclusions:  Our results show that the increasing IHD mortality in the NT Indigenous 
population is a consequence of a rise in AMI incidence, while at the same time there has 
been some improvement in Indigenous AMI survival rates. The simultaneous decrease in 
IHD mortality in NT non-Indigenous people was a result of reduced AMI incidence and 
improved survival after AMI in those admitted to hospital. Our results inform population-
MJA 2009; 190: 298–302
specific strategies for a systemwide response to AMI management.n 
(IH
deI the 1960s, ischaemic heart diseaseD) was the most common cause ofath among Australians, accounting for
a quarter of all deaths.1 Since then, IHD
death rates have fallen an average of 3.6%
As in Australia as a whole, IHD mortality
decreased in the Northern Territory over the
past two decades, but this decrease was
confined to the non-Indigenous popula-
tion.5 In contrast, deaths from IHD in the
Indigenous population increased by 5.7%
annually between 1977 and 1990, and con-
tinued to increase after 1990, albeit at a
slower rate of 1.1% annually, to 2001.6
The reasons for this difference are not
certain. The IHD incidence rate among
Indigenous Australians was calculated for
2002–2003 as three times higher than that
in the general population.7 However, long-
term national data on IHD incidence and
survival for Indigenous people are lacking.
We undertook this study to estimate the
incidence and mortality of acute myocardial
infarction (AMI) for the Indigenous and non-
Indigenous NT populations over the 13-year
period 1992–2004, and to explore risk fac-
tors for occurrence and death from AMI.
METHODS
Ischaemic heart disease includes AMI, angina
pectoris and other related conditions. How-
ever, the difficulty of obtaining reliable data
on angina pectoris and related conditions
means that monitoring of incidence and sur-
vival is necessarily confined to AMI events.4,8
Identification of new AMI cases
Almost all people who suffer an AMI in
Australia are admitted to hospital for treat-
ment, with the exception of those who die
suddenly. We used three sources to identify
new AMI cases: hospital inpatient records
and two sources of death registration data.
The five public hospitals in the NT share
a single patient-information system, in
which each patient is allocated a unique
hospital registration number. We identified
all inpatient episodes for NT residents with
any AMI diagnosis code from the NT hos-
pital separations dataset for the period 1
July 1990 to 31 December 2004. AMI
diagnosis codes comprised ICD-9 (Interna-
tional classification of diseases, 9th revi-
sion) code 410 (for 1990–1997) and ICD-
10 (ICD, 10th revision) code I21 (for
1998–2004). We collated inpatient epi-
sodes for all patients and identified the first
AMI episode. Patients with an AMI episode
in the 18-month clearance period before 1
January 1992 were excluded. During the
study period, the NT had one private hos-
pital; this hospital did not have coronary
care facilities, and patients diagnosed with
an AMI were routinely transferred to the
adjoining public hospital.
We used deaths data from the Australian
Bureau of Statistics (ABS) to identify all
deaths of NT residents from AMI that
occurred in Australia between 1 January
1992 and 31 December 2004. All deaths with
an underlying cause of IHD (ICD-9 codes
410–414 for 1992–1996; ICD-10 codes I20–
I25 for 1997–2004) were included. These
expanded codes were necessary as the dis-
tinction between AMI and other IHD subclas-
sifications in deaths data has been shown to
be unreliable.8 This approach was consistent
with that used in previous studies of national
AMI incidence.4,7
Combining hospital inpatient and ABS
death data created an overlapping list of
AMI cases. To eliminate the overlap, we
matched individuals identified in the hos-JA • Volume 190 Number 6 • 16 March 2009
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(NDI) held at the Australian Institute of
Health and Welfare using probabilistic
matching on names, date of birth and sex.9
Potential matches were verified manually.
We then separated matched cases from the
IHD deaths identified from the ABS data
using the death registration number, to
establish a list of new AMI patients who died
without hospital admission.
Matching across the three datasets created
three study cohorts: a group who died with-
out hospital admission; a second group who
were admitted to hospital and died as a
result of IHD; and a third group who were
admitted and either survived or died of
other causes.
Statistical analysis
We calculated age-specific and directly age-
standardised AMI incidence rates by age
group, sex, Indigenous status, year of diag-
nosis and residence (urban [Darwin and
Alice Springs] or remote), using the NT
population derived from ABS estimated resi-
dent population data. We used the 2001
Australian estimated resident population as
the standard population.
Three outcome measures were investigated:
AMI incidence; access to treatment (the pro-
portion of people who died without being
admitted to hospital); and survival after an
AMI (cause-specific mortality for all patients
and also for hospitalised patients). We used
regression modelling to assess the association
between each of these three outcome meas-
ures and five risk factors: sex (female versus
male), Indigenous status (Indigenous versus
non-Indigenous), residence (remote versus
urban), age at diagnosis (compared with
median age) and year of diagnosis (compared
with 1998). Negative binomial regression was
used to model AMI incidence; logistic regres-
sion to model the proportion of deaths with-
out hospitalisation; and proportional hazards
regression to model the risk of death after
AMI. Results are presented as incidence rate
ratio (IRR), odds ratio (OR) and hazard ratio
(HR), respectively.
Interaction terms were assessed by back-
ward selection for each outcome measure.
All interaction terms in the final models
included the risk factor “Indigenous status”,
indicating that the association between the
other risk factor in the term and the out-
come measure was different for Indigenous
and non-Indigenous people. In these cases,
the general estimate for the population
expressed the association for non-Indigen-
ous people. The association for Indigenous
people was calculated by multiplying the
estimate for the non-Indigenous population
by the estimate for the interaction term.
We censored data for survival analysis at
31 December 2004; patients who died from
a cause other than IHD before this date were
censored at the date of death. Survival time
was estimated as follows: for AMI patients
who were admitted to hospital and died of
IHD before the censoring date, the survival
time was the date of death minus the first
AMI admission date; for other patients
admitted to hospital with AMI, the survival
time was the censoring date minus the first
AMI admission date; and for those who died
without being admitted to hospital, survival
time was assumed to be 0.5 days.
All statistical analyses were performed
using Stata, version 10 (StataCorp, College
Station, Tex, USA).
Ethics approval
The study was approved by the Human
Research Ethics Committee of the NT
Department of Health and Families and the
Menzies School of Health Research. The
Human Research Ethics Committee of the
Australian Institute of Health and Welfare
approved access to the NDI.
RESULTS
We identified 3419 new AMI cases in NT
residents between 1 January 1992 and 31
December 2004 (Box 1). Of these, 1417
people (41%) were Indigenous, and 2414
(71%) were men. Median age was older for
women than for men, and also for non-
Indigenous than for Indigenous people.
Incidence of AMI
The univariate analysis showed that the age-
adjusted AMI incidence rate was higher for
Indigenous than for non-Indigenous people,
higher for men than for women, and higher
in remote areas than in urban areas for non-
Indigenous people, but not for Indigenous
people (Box 2). Incidence increased sharply
by age group.
National AMI incidence has been previ-
ously reported for the population aged 40
years or over.3 In this age group in the NT,
2 Age-adjusted incidence rate (95% CI) of acute myocardial infarction, Northern 
Territory, 1992–2004 (per 100 000 population)* 
Indigenous Non-Indigenous Total
Total 647 (609–685) 381 (361–401) 428 (410–445)
Sex
Men 842 (778–906) 488 (456–520) 539 (512–566)
Women 478 (433–524) 250 (226–274) 301 (280–322)
Residence
Urban 672 (594–750) 335 (315–355) 359 (340–379)
Remote 642 (598–686) 685 (610–760) 613 (577–650)
Age group (years)
20–39 153 (135–170) 15 (12–18) 46 (41–51)
40–64 765 (712–818) 231 (216–246) 326 (311–341)
 65 1507 (1333–1680) 1603 (1494–1713) 1565 (1473–1657)
* Data are number of new cases per 100 000 population (95% CI), age-adjusted to the 2001 Australian 
population. ◆
1 Demographic characteristics of people with new acute myocardial infarction, 
Northern Territory, 1992–2004, by Indigenous status
Indigenous Non-Indigenous Total population
Total no. 1417 2002 3419
Men, no. (%) 895 (63%) 1519 (76%) 2414 (71%)
Median age (years)
Men  51  61  57 
Women  55  70  62 
Remote residents, no. (%) 1039 (73%) 529 (26%) 1568 (45%)MJA • Volume 190 Number 6 • 16 March 2009 299
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people dropped between 1992 and 2004 by
23% (IRR, 0.98 per year; 95% CI, 0.95–
1.01). In the years for which national data are
available, AMI incidence rates for non-Indi-
genous NT men and women did not differ
greatly from national rates, and decreases
were at much the same rate (Box 3).
In contrast, the incidence rates among
Indigenous men and women aged 40 years
or over in the NT, although similar to NT
non-Indigenous and national rates at the
beginning of the study period, increased
between 1992 and 2004 by 48% (IRR, 1.03
per year; 95% CI, 1.00–1.07). By 1998,
these rates were about twice those in the
corresponding national populations (Box 3).
For the 20–39-year age group, AMI inci-
dence rates increased over the period 1992–
2004 in both the non-Indigenous and Indi-
genous NT populations, by 89% (IRR, 1.05;
95% CI, 0.98–1.13) and 116% (IRR, 1.07;
95% CI, 1.01–1.12), respectively.
After adjustment for risk factors (Box 4),
AMI incidence was 56% lower in women
than in men. For non-Indigenous people,
incidence increased with age by 10% per
year, was 102% higher in remote than urban
areas, and decreased by 20% between 1992
and 2004 (IRR, 0.98; 95% CI, 0.97–1.00).
For Indigenous people, incidence increased
with age by 6% per year (1.06; 95% CI,
1.05–1.06), was similar in urban and
remote areas (IRR, 1.05; 95% CI, 0.93–
1.21), and increased by 60% between 1992
and 2004 (IRR, 1.04 per year; 95% CI,
1.02–1.06).
The IRR for Indigenous compared with
non-Indigenous people varied by age at
diagnosis, year of diagnosis and residence
(Box 4). Compared with the non-Indige-
nous urban population, at the median age of
AMI diagnosis (58 years) Indigenous AMI
incidence was 95% higher in 1992 (IRR,
1.95; 95% CI, 1.60–2.37) and 290% higher
in 2004 (IRR, 3.90; 95% CI, 3.27–4.65).
Mortality from AMI
The proportion of deaths from AMI that
occurred without hospital admission (pre-
hospital deaths) was lower in women than
in men (OR, 0.75) and increased with age
(OR, 1.03 per year of age) (Box 4). The
proportion was also higher in Indigenous
than in non-Indigenous people (OR, 1.88, at
median age of diagnosis [58 years] and
middle year of study period [1998]).
For non-Indigenous people, the propor-
tion of AMI deaths without hospital admis-
sion was greater for remote than urban
residents (OR, 1.70) and did not change over
time (OR, 1.01). For Indigenous people, the
proportion was similar in remote and urban
areas (OR, 1.09; 95% CI, 0.85–1.40) and
decreased by 56% between 1992 and 2004
(OR, 0.93 per year; 95% CI, 0.91–0.96).
For patients admitted to hospital, the
death rate after an AMI was higher for
Indigenous than for non-Indigenous
patients (HR, 1.75 at median age of diagno-
sis and middle year of study period) (Box 4),
but decreased for both groups between
1992 and 2004, by 75% for non-Indigenous
people and 50% for Indigenous people (HR,
0.94 per year; 95% CI, 0.90–0.99). The
death rate for hospitalised patients did not
differ by sex or by remoteness of residence,
but did increase with age at diagnosis, by
7% per year for non-Indigenous patients
and 3% per year for Indigenous patients
(HR, 1.03; 95% CI, 1.02–1.05).
For all people with AMI (ie, with and
without hospital admission), the death rate
was higher for Indigenous than for non-
3 Incidence of acute myocardial infarction in populations aged 40 years in the 
Northern Territory (1992–2004), and in Australia (1993–1999)
4 Risk factors for incidence of acute myocardial infarction (AMI) and death from AMI, Northern Territory, 1992–2004 
Risk factor
AMI incidence rate 
ratio (95% CI)*
Odds ratio for 
pre-hospital death 
(95% CI)†




(n = 3419) 
Indigenous status (Indigenous v non-Indigenous) 2.76 (2.42–3.15) 1.88 (1.47–2.41) 1.75 (1.32–2.33) 1.44 (1.21–1.70)
Sex (female v male) 0.44 (0.40–0.48) 0.75 (0.64–0.88) 1.03 (0.82–1.30) 0.89 (0.80–0.99)
Age (v base age of 58 years) 1.10 (1.10–1.11)§ 1.03 (1.03–1.04) 1.07 (1.06–1.08)§ 1.03 (1.02–1.03)§
Residence (remote v urban) 2.02 (1.79–2.27)§ 1.70 (1.38–2.09)§ 1.08 (0.84–1.38) 1.26 (1.10–1.45)§
Year of diagnosis (v base year of 1998) 0.98 (0.97–1.00)§ 1.01 (0.98–1.03)§ 0.89 (0.86–0.93)§ 0.97 (0.96–0.98)
Interaction 1 (Indigenous  age)¶ 0.96 (0.95–0.96) na 0.97 (0.95–0.98) 0.99 (0.98–0.99)
Interaction 2 (Indigenous  remote)¶ 0.52 (0.44–0.63) 0.64 (0.47–0.88) na 0.84 (0.67–1.04)
Interaction 3 (Indigenous  year of diagnosis)¶ 1.06 (1.04–1.08) 0.93 (0.89–0.96) 1.05 (0.99–1.12) na
na = not applied in final model. * Estimated by negative binomial regression. † Estimated by logistic regression. ‡ Estimated by proportional hazards regression. 
§ The estimate of the association between the risk factor and outcome measure applies only to the non-Indigenous population. 
¶ The estimate for the interaction term indicates that the association with the relevant risk factor differed between Indigenous and non-Indigenous people. 
The association for Indigenous people was then calculated as the estimate for non-Indigenous people  estimate for interaction. 
For example, the AMI incidence rate ratio (IRR) of 0.52 for Interaction 1 (Indigenous  remote) meant that the effect of remote residence on AMI IRR was 48% lower 
for Indigenous than for non-Indigenous people. The AMI IRR for Indigenous people in a remote versus urban area was:
AMI IRR for residence (remote v urban) (2.02)  IRR for Interaction 1 (0.52) = 1.05. ◆300 MJA • Volume 190 Number 6 • 16 March 2009
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1.21–1.70) at median age at diagnosis for
urban cases (Box 4). The death rate was
11% lower for women than men, and
decreased by 29% between 1992 and 2004.
For non-Indigenous people, the death rate
increased with age at diagnosis by 3% per
year, and was 27% higher for remote than
urban residents. For Indigenous people, the
death rate increased with age at diagnosis by
2% per year (HR, 1.02; 95% CI, 1.01–1.02)
and was similar for remote and urban resi-
dents (HR, 1.06; 95% CI, 0.90–1.25).
DISCUSSION
We found that annual incidence of AMI in
the non-Indigenous population of the NT
was similar to that in the general Australian
population between 1993 and 1999, and
decreased at a similar rate during this time.4
During our study period, 1992–2004, there
was also a considerable increase in survival
rates for patients hospitalised with AMI.
Increased survival is consistent with the
growth of specialised coronary care services
and the growing emphasis on post-hospital
management of patients with AMI. How-
ever, offsetting this improvement was our
finding that the risk of pre-hospital death
changed little, so that the improvement in
non-Indigenous all-cases survival was
smaller than that in hospitalised patients
(death rates decreased by 29% and 75%,
respectively).
For the Indigenous population of the NT,
the pattern was different. AMI incidence was
similar to national rates in the early 1990s,
but increased in subsequent years (while the
national rate was falling) to be around  twice
the national rate by 1998. The increase in
incidence was offset by an improvement in
all-cases survival in the NT Indigenous pop-
ulation, a result of a decrease in both pre-
hospital mortality and mortality among
those who reached hospital (death rates
reduced by 56% and 50%, respectively).
The change in pre-hospital mortality indi-
cates a substantial improvement in early
management of AMI — a combination of
patients’ recognition and response to their
condition, initial primary health care man-
agement and access to hospital care. How-
ever, there is  still much room for
improvement, as Indigenous people with
AMI in the NT have a 44% higher risk of
death than non-Indigenous people.
From these results, we conclude that the
previously reported rising rate of deaths
associated with IHD5,6 in the NT Indigenous
population is due to increased incidence of
IHD in this population, moderated by the
effect of improved survival rates.
Our results also highlight the varying
contributions of sex and remote residence to
outcome. Being male or a non-Indigenous
resident of a remote area was associated with
increased risk of pre-hospital death, but had
no impact on mortality for those who
reached hospital. Urban residence was not
“protective” for the Indigenous population,
with those living in urban locations having a
similar rate of pre-hospital death as those
living in remote areas.
Many factors contribute to the poorer
outcomes observed for the Indigenous NT
population after first hospitalisation for
AMI. These include higher rates of AMI-
related risk factors, and poorer access to
coronary procedures that improve out-
comes.10,11 Access to procedures is itself
influenced by the individual’s preference
and consent to treatment, geographic
remoteness and clinical decision making.12
The rate of coronary procedures has been
reported as being lower for Indigenous than
non-Indigenous people, not only during the
index admission but also during subsequent
admissions.10 Other factors that influence
outcome include delays to hospital presen-
tation,13 affordability of medications, com-
pliance with clinical management plans and
access to primary care services.14
In addition, the difference in AMI inci-
dence between remote and urban non-
Indigenous populations reinforces the need
for tailored responses to improve outcomes
in different populations.
Our study had several limitations. Retro-
spective linking of hospital and deaths data
provided a reliable, but not perfect, data
source.9,15-20 For example, 40 of 667
patients (6%) known from hospital data to
have died were not identified as deceased
when matched to the NDI. Data may also
have been duplicated for patients with more
than one hospital admission and a variation
in their identification details.
A further limitation was that some people
with AMI may have been missed because
they were misdiagnosed or not admitted to
hospital. Missed cases would result in
underestimation of true AMI incidence. Sur-
vival might also be underestimated because
patients missed from hospital data survived
the AMI. This effect would be balanced by
those early deaths that were incorrectly
attributed as AMI deaths. However, these
deficits would have little effect on time
trends.
A 2003 study in Western Australia
showed the importance of a clearance
period in data collection, reporting a 13%
overestimation of AMI incidence in the early
years of studies that did not use such a
period.21 We incorporated a 1.5-year clear-
ance period into our study, which maxim-
ised the availability of hospital cases within
the available dataset, but a small proportion
of previous AMI admissions may have been
overlooked.
Our study demonstrates the usefulness of
routinely collected data for investigating
population health trends and health system
performance that previously could not be
measured, particularly on a systemwide
basis. The national study of AMI incidence
and case fatality was not able to measure
survival rates, as data for individuals could
not be linked.4
In this study, the availability of unique
patient identifiers across all NT public hos-
pitals allowed the separate calculation of the
proportion of people who died without hos-
pital admission, and survival rates for hospi-
talised patients. These data provide
important measures of health system per-
formance, including rates of access to acute
care (proportion who died without hospital
admission), health service performance
(survival for hospitalised patients) and an
integrated measure of “whole system” per-
formance (survival for all people after
AMI).22 The different patterns of change
over time for Indigenous and non-Indigen-
ous people with AMI highlight the different
issues that need to be addressed in each
population group.
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